GlassScriptPhysician profile
John A Fortney
NPI 1215026372
$644.66
in general payments reported to CMS, 2019-2025
13 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.49 · 2020: $89.76 · 2021: $15.87 · 2022: $20.53 · 2023: $272 · 2024: $33.19 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.01 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visionrt, INC. | $164.55 | 2023 | |
| Janssen Biotech, INC. | $99.00 | 2025 | Rybrevant |
| Astrazeneca Pharmaceuticals LP | $96.51 | 2020-2023 | Tagrisso |
| Pfizer INC. | $67.80 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.27 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $32.39 | 2025 | Dupixent |
| Tactile Systems Technology INC | $31.39 | 2023 | Flexitouch Plus, Entre Plus |
| Celgene Corporation | $23.56 | 2019 | |
| Exelixis INC. | $22.22 | 2023 | Cabometyx |
| Gt Medical Technologies, INC | $20.53 | 2022 | |
| Boston Scientific Corporation | $17.75 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.60 | 2020 | |
| Amgen INC. | $12.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Fortney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.